Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetaminophen (tylenol) (1 trial)
aminocaproic acid (amicar) (1 trial)
epinephrine (levophed) (1 trial)
lidocaine (xylocaine) (1 trial)
bortezomib (velcade) (1 trial)
clobetasol (dermovate) (1 trial)
cyclophosphamide (cytoxan) (3 trials)
daratumumab (darzalex) (1 trial)
dexamethasone (2 trials)
melphalan (alkeran) (1 trial)
prednisone (meticorten) (1 trial)
thalidomide (Thalomid) (4 trials)
urea (3 trials)
Graft vs Host Disease (Phase 3)
Hemorrhage (Phase 4)
Multiple Myeloma (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Oral Hemorrhage (Phase 4)
Oral Manifestations (Phase 3)
Trials (6 total)
Trial APIs (13 total)